Filing Details
MANGOCEUTICALS, INC. (NASDAQ:MGRX) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event.
8k filedNASDAQ:MGRX
MANGOCEUTICALS, INC. (MGRX) Reports Material Event to SEC
Filing Details MANGOCEUTICALS, INC. (NASDAQ:MGRX) filed a Form 8-K with the Securities and Exchange Commission on July 02, 2026, disclosing a material event. Market Context…
Market Context
MANGOCEUTICALS, INC.'s stock currently trades at $0.47 with a market capitalization of $12.9M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for MANGOCEUTICALS, INC.'s stock.
All SEC filings for MANGOCEUTICALS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MGRX Stock Page
Frequently Asked Questions
Where can I read MGRX's SEC filings?
Browse all filings on our MGRX SEC filings page.
What types of SEC filings does MANGOCEUTICALS, INC. file?
Public companies like MANGOCEUTICALS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.